# Genito-urinary System - BNF Chapter 7

Source: https://www.rightdecisions.scot.nhs.uk/dgrefhelp-nhs-dumfries-galloway/dg-formulary/genito-urinary-system-bnf-chapter-7/
Fetched: 2026-02-23

## 1. Bladder and urinary disorders

- Oxybutynin Immediate release ✓ First Choice
- Solifenacin
- Mirabegron – Note: To be considered where 2 separate trials of anti-muscarinics have not been effective or where first line options are contraindicated. This may be considered a first line option in patients with a high anti-cholinergic burden would be detrimental. In line with Scottish Polypharmacy Guidance 2015.


### Stress Urinary Incontinence in Women

- Pelvic floor muscle exercises

See national guidance -

- Nice guidance - Men
- Nice guidance women
- Management of Incontinence - urinary, in women - CKS 


### Alpha-andrenoceptor blockers

- Tamsulosin caps ✓ First Choice
- Alfuzosin ✓ First Choice
- Doxazosin


### 5α-reductase inhibitors

- Finasteride ✓ First Choice
- Dutasteride

Consider alpha-adrenoceptor blockers in patients with distal ureteric stones less than 10mm in diameter


### Alkalinisation of urine

- Potassium citrate ✓ First Choice

## 2. Bladder instillations and urological surgery


### Bladder infection, dissolution of blood clots and maintenance of indwelling urinary catheters

- Sodium chloride 0.9%

## 3. Contraception

Refer to sexual health guidelines at – West of Scotland sexual health guidelines


### Combined hormonal contraceptives - oral


#### 1st generation

- Brevinor® ✓ First Choice


#### 2nd generation – ethinylestradiol + levonorgestrel

- Levest® 150/30 ✓ First Choice
- Rigevidon® ✓ First Choice


#### Triphasic

- TriRegol® ✓ First Choice


#### 3rd generation – ethinylestradiol + desogestrel

- Bimizza® 150/20 ✓ First Choice
- Cimizt 30/150 ✓ First Choice


#### 3rd Generation – ethinylestradiol + gestodene

- Millinette 30/75 and 20/75


#### 3rd Generation – ethinylestradiol + norgestimate

- Lizinna® 250/35 (replaces Cilique® 250/35)


#### 4th Generation

- Yacella


### Combined hormonal contraceptives – transdermal

- Evra® patches (ethinylestradiol + norelgestromin)


### Combined hormonal contraceptives – vaginal

- Nuvaring (ethinylestradiol + etonogestrel)


### Inter-uterine devices

- TT 380® Slimline 10 year IUD
- Short uterus – Mini TT 380® Slimline (5 year)
- Narrow os – Nova-T® 380 (5 year)
- Narrow os and short uterus CU-Safe® T 300 (5 year)


### Diaphragms/caps 

Seek advice from sexual health on the most cost effective product at the time of prescribing

- Copper IUD should be offered first line ✓ First Choice


### Hormonal Emergency Contraception

- Ulipristal acetate 30mg ✓ First Choice effective up to 120hrs
- Levonorgestrel 1.5mg effective up to 96hrs

See FSRH guidance (December 2017 – updated 2023) for clarification on when Ulipristal or levonorgestrel is most appropriate, for changes in relation to weight/ unprotected sex during the 5 days prior to the estimated day of ovulation/ progestogen taken in the preceding 7 days or if progestogen to be quick started etc. Faculty of Sexual and Reproductive Healthcare guidance

- Desogestrel (12 hour window) ✓ First Choice


### LARC parenteral progestogen - only

- Medroxyprogesterone acetate 150mg/1ml (Depo-Provera®) ✓ First Choice
- Medroxyprogesterone acetate 104mg/0.65ml (Sayana Press®) for self-administration.


### LARC - Contraceptive implants

- Etonogestrel (Nexplanon®) ✓ First Choice


### LARC - Hormone releasing intra-uterine systems

- Levosert® (LNG 52mg)
- Benilixa® (LNG 52mg)
- Mirena® (LNG 52mg)
- Kyleena ® (LNG 19.5mg)
- Jaydess® (LNG 13.5mg)

## 4. Erectile and ejaculatory conditions

Prescription must be endorsed ‘SLS’ by the prescriber. Only allowed on the NHS as per criteria listed in BNF chapter 7.4.1

- Sildenafil tablets ✓ First Choice(Guidance states that no more than 8 per 4 week period should be prescribed )
- Alprostadil injection (Caverject Dual Chamber®)
- Alprostadil urethral cream (Vitaros®)

Specialist treatment

 

## 5. Polycystic ovarian syndrome

- Metformin - unlicensed indication

## 7. Obstetrics

- Dinoprostone ✓ Specialist Use Only
- Oxytocin ✓ Specialist Use Only

- Oxytocin ✓ Specialist Use Only
- Tranexamic acid ✓ Specialist Use Only
- Ergometrine ✓ Specialist Use Only
- Carboprost ✓ Specialist Use Only
- Ergometrine/oxytocin (syntometrine) ✓ Specialist Use Only

- Atosiban ✓ Specialist Use Only

- Mifepristone ✓ Specialist Use Only
- Misoprostol ✓ Specialist Use Only


### Hospital management - Ectopic pregnancy

- Methotrexate ✓ Specialist Use Only


### Hospital management- Suppression of Lactation

- Cabergoline ✓ Specialist Use Only/li>


### Hospital management - Uterine hyperstimulation

- Terbutaline injection ✓ Specialist Use Only

## 8. Vaginal and vulval conditions


### Lichen sclerosis

- Clobetasol propionate 0.05% ointment


### Vulval moisturizers (Can be used as a wash/ soap substitute)

- Epimax ointment
- Hydromol ointment
- Doublebase gel or equivalent emollient


### Vaginal Atrophy


### Vaginal Oestrogen Products


#### Symptom control

- Hyalofemme®
- Sylk® VM
- YES® VM


### Dysmenorrhoea

- Ibuprofen
- Paracetamol


### Oligomenorrhoea

- See section on combined oral contraception
- Medroxyprogesterone acetate

## 9. Thyroid disorders


### Antithyroid drugs

To be initiated on specialist advice

- Carbimazole ✓ First Choice
- Propylthiouracil – Patients should be counselled re risk of hepatitis (see SPC at www.medicines.org.uk )


### Beta-blockers

- Propranolol

- Levothyroxine ✓ First Choice

MHRA Dryg Safety Update 2021: levothyroxine new prescribing advice for patients whoexperience symptoms on switching between different levothyroxine products

- Liothyronine Specialist initiation

Hypoparathyroidism

- Alfacalcidol
- Calvive® 1000

Hyperparathyroidism

- Cinacalcet

---
## Editorial Information

- **Last reviewed:** 25/04/2025
- **Next review date:** 30/04/2027
- **Author(s):** Formulary subgroup of ADTC.
- **Version:** 1.0
- **Approved By:** ADTC
